Oh, S.; Park, Y.; Lee, H.-J.; Lee, J.; Lee, S.-H.; Baek, Y.-S.; Chun, S.-K.; Lee, S.-M.; Kim, M.; Chon, Y.-E.;
et al. A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy. Cancers 2020, 12, 745.
https://doi.org/10.3390/cancers12030745
AMA Style
Oh S, Park Y, Lee H-J, Lee J, Lee S-H, Baek Y-S, Chun S-K, Lee S-M, Kim M, Chon Y-E,
et al. A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy. Cancers. 2020; 12(3):745.
https://doi.org/10.3390/cancers12030745
Chicago/Turabian Style
Oh, Sooyeon, YoungJoon Park, Hyun-Jung Lee, Jooho Lee, Soo-Hyeon Lee, Young-Seok Baek, Su-Kyung Chun, Seung-Min Lee, Mina Kim, Young-Eun Chon,
and et al. 2020. "A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy" Cancers 12, no. 3: 745.
https://doi.org/10.3390/cancers12030745
APA Style
Oh, S., Park, Y., Lee, H.-J., Lee, J., Lee, S.-H., Baek, Y.-S., Chun, S.-K., Lee, S.-M., Kim, M., Chon, Y.-E., Ha, Y., Cho, Y., Kim, G. J., Hwang, S.-G., & Kwack, K.
(2020). A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy. Cancers, 12(3), 745.
https://doi.org/10.3390/cancers12030745